335 related articles for article (PubMed ID: 33590842)
1. Type 2 diabetes mellitus, glycaemic control, associated therapies and risk of rheumatoid arthritis: a retrospective cohort study.
Zemedikun DT; Gokhale K; Chandan JS; Cooper J; Lord JM; Filer A; Falahee M; Nirantharakumar K; Raza K
Rheumatology (Oxford); 2021 Dec; 60(12):5567-5575. PubMed ID: 33590842
[TBL] [Abstract][Full Text] [Related]
2. Important differences in the durability of glycaemic response among second-line treatment options when added to metformin in type 2 diabetes: a retrospective cohort study.
Mamza J; Mehta R; Donnelly R; Idris I
Ann Med; 2016; 48(4):224-34. PubMed ID: 26982210
[TBL] [Abstract][Full Text] [Related]
3. Sex Differences in Cardiovascular Effectiveness of Newer Glucose-Lowering Drugs Added to Metformin in Type 2 Diabetes Mellitus.
Raparelli V; Elharram M; Moura CS; Abrahamowicz M; Bernatsky S; Behlouli H; Pilote L
J Am Heart Assoc; 2020 Jan; 9(1):e012940. PubMed ID: 31902326
[TBL] [Abstract][Full Text] [Related]
4. Risks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide longitudinal study.
Ou HT; Chang KC; Li CY; Wu JS
Cardiovasc Diabetol; 2016 Mar; 15():41. PubMed ID: 26932742
[TBL] [Abstract][Full Text] [Related]
5. Adherence to metformin and the onset of rheumatoid arthritis: a population-based cohort study.
Naffaa ME; Rosenberg V; Watad A; Tiosano S; Yavne Y; Chodick G; Amital H; Shalev V
Scand J Rheumatol; 2020 May; 49(3):173-180. PubMed ID: 32208872
[No Abstract] [Full Text] [Related]
6. Dipeptidyl peptidase-4 inhibitors in type 2 diabetes may reduce the risk of autoimmune diseases: a population-based cohort study.
Kim SC; Schneeweiss S; Glynn RJ; Doherty M; Goldfine AB; Solomon DH
Ann Rheum Dis; 2015 Nov; 74(11):1968-75. PubMed ID: 24919467
[TBL] [Abstract][Full Text] [Related]
7. Metformin Treatment Is Associated with a Decreased Risk of Nonproliferative Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus: A Population-Based Cohort Study.
Fan YP; Wu CT; Lin JL; Hsiung CA; Liu HY; Lai JN; Yang CC
J Diabetes Res; 2020; 2020():9161039. PubMed ID: 32377525
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of lactic acidosis in type 2 diabetes patients with metformin in Japan.
Chang CH; Sakaguchi M; Dolin P
Pharmacoepidemiol Drug Saf; 2016 Oct; 25(10):1196-1203. PubMed ID: 27221971
[TBL] [Abstract][Full Text] [Related]
9. Combination of COX-2 inhibitor and metformin attenuates rate of admission in patients with rheumatoid arthritis and diabetes in Taiwan.
Lu CH; Chung CH; Lee CH; Su SC; Liu JS; Lin FH; Tsao CH; Hsieh PS; Hung YJ; Hsieh CH; Chien WC
Medicine (Baltimore); 2019 Oct; 98(41):e17371. PubMed ID: 31593087
[TBL] [Abstract][Full Text] [Related]
10. The association between diabetes, level of glycaemic control and eye infection: Cohort database study.
Ansari AS; de Lusignan S; Hinton W; Munro N; McGovern A
Prim Care Diabetes; 2017 Oct; 11(5):421-429. PubMed ID: 28648963
[TBL] [Abstract][Full Text] [Related]
11. Third-Line Antidiabetic Therapy Intensification Patterns and Glycaemic Control in Patients with Type 2 Diabetes in the USA: A Real-World Study.
Koye DN; Montvida O; Paul SK
Drugs; 2020 Apr; 80(5):477-487. PubMed ID: 32141024
[TBL] [Abstract][Full Text] [Related]
12. Dipeptidyl peptidase-4 inhibitors lower the risk of autoimmune disease in patients with type 2 diabetes mellitus: A nationwide population-based cohort study.
Seong JM; Yee J; Gwak HS
Br J Clin Pharmacol; 2019 Aug; 85(8):1719-1727. PubMed ID: 30964554
[TBL] [Abstract][Full Text] [Related]
13. Effects of background statin therapy on glycemic response and cardiovascular events following initiation of insulin therapy in type 2 diabetes: a large UK cohort study.
Anyanwagu U; Mamza J; Donnelly R; Idris I
Cardiovasc Diabetol; 2017 Aug; 16(1):107. PubMed ID: 28830436
[TBL] [Abstract][Full Text] [Related]
14. Risk of Incident Type 2 Diabetes Mellitus Among Patients With Rheumatoid Arthritis: A Population-Based Cohort Study.
Jin Y; Chen SK; Liu J; Kim SC
Arthritis Care Res (Hoboken); 2020 Sep; 72(9):1248-1256. PubMed ID: 32754989
[TBL] [Abstract][Full Text] [Related]
15. Glycaemic control among patients with type 2 diabetes mellitus in seven European countries: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) study.
Alvarez Guisasola F; Mavros P; Nocea G; Alemao E; Alexander CM; Yin D
Diabetes Obes Metab; 2008 Jun; 10 Suppl 1():8-15. PubMed ID: 18435669
[TBL] [Abstract][Full Text] [Related]
16. Increased Risk of Chronic Kidney Disease in Rheumatoid Arthritis Associated with Cardiovascular Complications - A National Population-Based Cohort Study.
Chiu HY; Huang HL; Li CH; Chen HA; Yeh CL; Chiu SH; Lin WC; Cheng YP; Tsai TF; Ho SY
PLoS One; 2015; 10(9):e0136508. PubMed ID: 26406879
[TBL] [Abstract][Full Text] [Related]
17. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
18. Real-world Evaluation of glycemic control and hypoglycemic Events among type 2 Diabetes mellitus study (REEDS): a multicentre, cross-sectional study in Thailand.
Satirapoj B; Pratipanawatr T; Ongphiphadhanakul B; Suwanwalaikorn S; Benjasuratwong Y; Nitiyanant W
BMJ Open; 2020 Feb; 10(2):e031612. PubMed ID: 32051301
[TBL] [Abstract][Full Text] [Related]
19. Risk of diabetes mellitus associated with disease-modifying antirheumatic drugs and statins in rheumatoid arthritis.
Ozen G; Pedro S; Holmqvist ME; Avery M; Wolfe F; Michaud K
Ann Rheum Dis; 2017 May; 76(5):848-854. PubMed ID: 27836820
[TBL] [Abstract][Full Text] [Related]
20. Mean HbA1c and mortality in diabetic individuals with heart failure: a population cohort study.
Elder DH; Singh JS; Levin D; Donnelly LA; Choy AM; George J; Struthers AD; Doney AS; Lang CC
Eur J Heart Fail; 2016 Jan; 18(1):94-102. PubMed ID: 26663216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
